EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT.
D000493:Allopurinol; D001168:Arthritis; D001769:Blood; D001855:Bone Marrow Diseases; D004358:Drug Therapy; D004791:Enzyme Inhibitors; D005441:Fluids and Secretions; D006073:Gout; D006801:Humans; D008660:Metabolism; D010600:Pharmacology; D011087:Polycythemia Vera; D011720:Pyrazoles; D011743:Pyrimidines; D014116:Toxicology; D014527:Uric Acid; D014528:Uricosuric Agents; D014545:Urinary Calculi; D014556:Urine; D014969:Xanthine Oxidase
D004791:Enzyme Inhibitors; D011720:Pyrazoles; D011743:Pyrimidines; D014528:Uricosuric Agents; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase; C030986:pyrimidine
ARTHRITIS; BLOOD; BONE MARROW DISEASES; DRUG THERAPY; ENZYME INHIBITORS; EXCRETION; GOUT; METABOLISM; PHARMACOLOGY; POLYCYTHEMIA VERA; PYRAZOLES; PYRIMIDINES; TOXICOLOGIC REPORT; URIC ACID; URICOSURIC AGENTS; URINARY CALCULI; URINE; XANTHINE OXIDASE